Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine

Clinical trial NCT00734175 · COMPLETED

Trial details

NCT number: NCT00734175
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Influenza Virus Diseases

Start date: 2008-09-01
Primary completion: 2008-12-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.